The effect of coverage of smoking-cessation aids on tobacco use: Evidence from Canada

Yichen Shen*, Haruko Noguchi

*この研究の対応する著者

研究成果: Article査読

抄録

In clinical trials, smoking-cessation aids (SCAs) have proven to be effective at improving the odds of smoking cessation. Because of the effectiveness of SCAs in these settings, many countries have adopted the coverage of SCAs to reduce tobacco use. However, the effect of such coverage on tobacco use is ambiguous. On one hand, the coverage may have the intended effect and reduce tobacco use. On the other hand, the coverage may cause beneficiaries to participate in tobacco use more as the drug coverage protects beneficiaries from future costs associated with tobacco use. To understand the effect of SCA coverage, we examine it using 2008–2012 Canadian Tobacco Use Monitoring Survey and a difference-in-differences approach. We find that SCA coverage increases cigarette and cigarillo use. Moreover, the effect of SCA coverage on tobacco use is stronger in men and in those with at least a college education. Our results point to the unintended consequences of the coverage of SCAs on tobacco use.

本文言語English
ページ(範囲)2200-2216
ページ数17
ジャーナルHealth Economics (United Kingdom)
30
9
DOI
出版ステータスPublished - 2021 9

ASJC Scopus subject areas

  • 健康政策

フィンガープリント

「The effect of coverage of smoking-cessation aids on tobacco use: Evidence from Canada」の研究トピックを掘り下げます。これらがまとまってユニークなフィンガープリントを構成します。

引用スタイル